Classification of the vasculitides has been traditionally based on vessel size. The American
College of Rheumatology (ACR) criteria were developed in the 1980s and published in …

Objective To develop and validate a prognostic model to inform risk stratified decisions on
frequency of monitoring blood tests during long term methotrexate treatment. Design …

Objectives To examine temporal trends in all-cause and cause-specific mortality in RA.
Methods Data from the Clinical Practice Research Datalink were used. Incident RA cases …

Background Pain is a major challenge for patients with rheumatoid arthritis (RA), with many
people suffering chronic pain. Current RA management guidelines focus on assessing and …

Objectives To examine incidence of treatment changes due to abnormal blood-test results
and, to explore rates of treatment changes due to liver, kidney and haematological blood …

Objectives To assess whether modern management of RA has reduced the prescription of
oral corticosteroids and NSAIDs and to evaluate use of pharmacological prophylaxis …

The use of administrative health datasets is increasingly important for research on disease
trends and outcome. The Western Australian (WA) Rheumatic Disease Epidemiological …

Background: Certain immunosuppressant drugs are known to increase the risk of myeloid
neoplasms although it is unclear if underlying autoimmune disorder itself increases the risk …

This study aimed at providing a current and nearly complete picture of the patterns of the
initiation of disease-modifying antirheumatic drugs (DMARDs) in patients with newly …

Background Disease-modifying anti-rheumatic drugs (DMARDs), including methotrexate
and azathioprine, are commonly used to treat rheumatoid arthritis (RA) and inflammatory …